Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
22/03/2023 07:15
March 22 (Reuters) - Hybrigenics SA ALHYG.PA :
* HYBRIGENICS PRESENTS THE PROGRESS OF ITS SUBSIDIARY B CELL
DESIGN, SPECIALIZED IN THE DEVELOPMENT OF ARTIFICIAL ANTIBODIES
Source text for Eikon: ID:nACT79000
Further company coverage: ALHYG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;;))
Recent news on Aton SA
See all newsBrief: Hybrigenics SA Says Hybrigenics Re-Brands To 'Aton', Commits EUR 15Million To Support Its New Growth And Development Strategy Over Next Three Years
Brief: Hybrigenics 2022 Net Loss EUR 0.5 Million
Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
Brief: Hybrigenics Targets EUR 60 Mln Of Turnover By 2025
Brief: Hybrigenics H1 Operating Loss Widens To EUR 0.2 Million